this can cause nausea, bloating, and prolonged fullness, particularly during dose escalation
We built this tracker to give patients an easier way to navigate GLP-1 shortages, by: 1 Clearly showing which GLP-1s are currently in shortage by drug and dose 2 Making it easy for everyone to crowdsource where and when they find GLP-1 supply or, when they cannot, to submit a shortage report to the FDA 3 Letting anyone join our Supply List that sends real-time alerts when GLP-1 supply is located at a pharmacy near them 4 Sending automated notifications to patients and providers who sign-up letting them know when a drugs status changes on the FDAs list
The company built its proprietary Precision Endocrine Peptide (PEP) platform to engineer peptide hormones with extended time-action profiles, aiming to overcome the dosing-frequency and tolerability limitations of earlier peptide therapeutics, including in the obesity space
Key Summary Firm still selling illegal trial drug replicas online MHRA seized thousands of unlicensed injections in October Experts warn of safety risks, especially in winter The company associated with the sale of counterfeit versions of a weight-loss medicine continues to be in business, despite a Medicines and Healthcare products Regulatory Agency (MHRA) raid in October
